Summary
Evolin is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.0m and a net result of €129,607. Equity is growing by ~53.3% per year across the filed fiscal years. Its solvency ranks better than 65% of 9727 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-09
State Gazette act
Registered officeRegistered-office move2 facts ▸
State Gazette act
Registered office
Registered-office move2 facts ▸
- Board meeting, 03-09-2026
- Registered-office move, Dr.-Van de Perrestraat 29, 2440 Geel
16-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
07-01
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 160 days late
2025
31-12
Financial
Highest result since 2023net €129,607 ▲53.6%
Operating result €194,363, net result €129,607, both a record.
31-12
Financial
Equity above €1mEq €1.0m ▲14.2%
3 profitable years in a row build equity to €1.0m.
2024
31-12
Financial
Equity above €500,000Eq €912,959 ▲1,231%
2 profitable years in a row build equity to €912,959.
25-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 3 acts read
About the unread acts
Of the 3 Belgian State Gazette acts we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.